Cargando…

Residual neuromuscular block in the postanesthesia care unit: incidence, risk factors, and effect of neuromuscular monitoring and reversal agents

BACKGROUND/AIM: The aim of this study was to determine the incidence of residual neuromuscular block (RNMB) in a tertiary care hospital. Secondary goals were to examine the characteristics of the use of intraoperative neuromuscular monitoring (NMM) and different reversal agents by the attending anes...

Descripción completa

Detalles Bibliográficos
Autores principales:	ÖZBEY, Nazlı Bahar, ABDULLAH, Taner, DELİGÖZ, Özlem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific and Technological Research Council of Turkey (TUBITAK) 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395735/ https://www.ncbi.nlm.nih.gov/pubmed/36422506 http://dx.doi.org/10.55730/1300-0144.5507

Ejemplares similares

Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo
por: Wu, Yan, et al.
Publicado: (2022)

Reversal of neuromuscular block
por: Bhalotra, Anju Romina
Publicado: (2018)

Reversal agent is mandatory even with neuromuscular monitoring!
por: Mehandale, Sripada Gopalakrishna, et al.
Publicado: (2018)

Neuromuscular blocking agents in the intensive care unit
por: Rodríguez-Blanco, Jonathan, et al.
Publicado: (2022)

Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
por: Domenech, Gonzalo, et al.
Publicado: (2019)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019)

Reversal of neuromuscular block: what are the costs?
por: Bartels, Karsten, et al.
Publicado: (2023)

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
por: Ledowski, Thomas, et al.
Publicado: (2013)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
por: Cho, Sung-Ae, et al.
Publicado: (2022)

For the peace of postanesthesia care unit
por: Hwang, Sung Mi
Publicado: (2018)

Potentially disastrous reversal of neuromuscular block agents before removing Mayfield head holder
por: Santos, Christiano dos Santos e, et al.
Publicado: (2020)

Reversal agents: do we need to administer with neuromuscular monitoring – an observational study
por: Goyal, Shilpa, et al.
Publicado: (2018)

Response to comments on “Reversal agents: Do we need to administer with neuromuscular monitoring”
por: Goyal, Shilpa, et al.
Publicado: (2018)

Neuromuscular monitoring and neuromuscular blocking agent shortages when treating critically ill COVID-19 patients: a multicentre retrospective analysis
por: Ziatkowski-Michaud, Julia, et al.
Publicado: (2021)

Tracheal Intubation Without the Use of Neuromuscular Blocking Agents
por: Prakash, Smita
Publicado: (2012)

Neuromuscular blocking agents for acute respiratory distress syndrome
por: Torbic, Heather, et al.
Publicado: (2019)

Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
por: Gonçalves, Pedro Marcos Silva e, et al.
Publicado: (2020)

Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management
por: Wu, HaoTian, et al.
Publicado: (2022)

Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: an ex vivo laboratory study
por: Fábián, Ákos I., et al.
Publicado: (2021)

Urgent intubation without neuromuscular blocking agents and the risk of tracheostomy
por: Fujinaga, Jun, et al.
Publicado: (2019)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)

REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study)
por: Greco, Massimiliano, et al.
Publicado: (2023)

Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade
por: Thilen, Stephan R., et al.
Publicado: (2016)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
por: Carlos, Ricardo Vieira, et al.
Publicado: (2017)

Postoperative residual block in postanesthesia care unit more than two hours after the administration of a single intubating dose of atracurium(*)
por: Varposhti, Mojtaba Rahimi, et al.
Publicado: (2011)

Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade With E-Learning: Protocol for the Multicenter Interrupted Time Series INVERT Study
por: Thomsen, Jakob Louis Demant, et al.
Publicado: (2017)

Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Byum, et al.
Publicado: (2017)

Potential cross-allergic reaction from pholcodine and neuromuscular blocking agents
Publicado: (2022)

Is it appropriate for acute respiratory distress syndrome patients with neuromuscular blocking agents?
por: Tan, Zhimin, et al.
Publicado: (2023)

Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
por: Hafeez, Khawaja Rashid, et al.
Publicado: (2018)

Postoperative pain management in the postanesthesia care unit: an update
por: Luo, Jie, et al.
Publicado: (2017)

The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex
por: Lee, Hee Jong, et al.
Publicado: (2015)

Development of an algorithm using clinical tests to avoid post-operative residual neuromuscular block
por: Unterbuchner, Christoph, et al.
Publicado: (2017)

Neuromuscular monitoring: An assistant not an alternative
por: Tak, Himani, et al.
Publicado: (2018)

Intraoperative Monitoring of Neuromuscular Blockade
por: Motamed, Cyrus
Publicado: (2023)

Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions
por: Hagau, Natalia, et al.
Publicado: (2013)

Endotracheal Intubation Without Neuromuscular Blocking Agents: Is It a Good and Safe Option?
por: Akan, Mert, et al.
Publicado: (2012)

Erratum: Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Beom, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6m95q7s16if0oo171rha9qs9au